A clinical trial to study the effects of two techniques, myofascial release therapy and chest exercises on functions of the lungs and mobility of the chest wall in individuals with old respiratory condition.

Immediate effects of myofascial release therapy and thoracic mobility exercises on lung functions and chest mobility in individuals with chronic obstructive pulmonary disease: An Experimental Crossover Study. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057416

Enrollment

Registered

2023-09-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Myofascial Release Therapy: The myofascial release therapy will be given by the investigator for three sites with holds of 3-5 mins till the fascia feels loose. Intervention2: Myofascia

Eligibility

Inclusion criteria

Inclusion criteria: a) Participants diagnosed with Chronic Obstructive Pulmonary Disease (COPD) b) All genders c) Aged between 40 to 60 years d) Stable condition for the past month (no exacerbation of symptoms)

Exclusion criteria

Exclusion criteria: a)Other Cardiorespiratory disorders (Grade 3 & 4 CCF) b) Patients who have undergone recent cardiothoracic or abdominal surgery. c) Patients who have a recent history of chest wall or abdominal trauma; substantial chest wall deformity d) Dyspnea grade 4 on mMRC scale e) Known contraindications to myofascial release therapy (malignancy, tumours, Rheumatoid arthritis, osteoporosis) f) Pregnancy g) Neuromuscular or musculoskeletal pathology

Design outcomes

Primary

Measure	Time frame
a) To evaluate the immediate effect of myofascial release therapy on lung functions & chest mobility in COPD using pulmonary function test (FEV1, FVC, VC, RV, ERV & TLC) & chest expansion measurement by tape method respectively. b)To evaluate the immediate effect of thoracic mobility exercise on lung functions and chest mobility in COPD using pulmonary function test (FEV1, FVC, VC, RV, ERV and TLC) and chest expansion measurement by tape method respectively. c) To compare the immediate effects of myofascial release therapy and thoracic mobility exercises on lung functions and chest mobility in COPD.Timepoint: The assessment will be taken before the start of the intervention & immediately after the intervention.	—

Measure

Time frame

a) To evaluate the immediate effect of myofascial release therapy on lung functions & chest mobility in COPD using pulmonary function test (FEV1, FVC, VC, RV, ERV & TLC) & chest expansion measurement by tape method respectively. b)To evaluate the immediate effect of thoracic mobility exercise on lung functions and chest mobility in COPD using pulmonary function test (FEV1, FVC, VC, RV, ERV and TLC) and chest expansion measurement by tape method respectively. c) To compare the immediate effects of myofascial release therapy and thoracic mobility exercises on lung functions and chest mobility in COPD.Timepoint: The assessment will be taken before the start of the intervention & immediately after the intervention.

—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Shweta Manwadkar

K J Somaiya College of Physiotherapy

principal.physiotherapy@somaiya.edu8104017576

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026